As I mentioned in the original post, I was the first person in the history of MD Anderson to have small cell lung cancer metastasized throughout my entire body (neck, lungs, stomach, liver, pancreas and bones) and live to tell the tale. 12 weeks ago, another patient, identical to me in small cell metastasis and also a patient at MD Anderson, started the regimen.
This week, we received word of another ovarian cancer cure. Completely gone without surgery. We also have a breast cancer lady who has been getting progressively worse for 3 years. Tried to get her on Panacur a year ago. After her last chemo, she was told the cancer had spread to her liver, lymph nodes, and bones. So
In the past two weeks, I have received word from 4 more success stories ranging from Pancreatic cancer (2nd stage) to non small cell lung cancer that had metastasized to mutiple organs to another success story with colo-rectal cancer to a crazy success with an inoperable large tumor wrapped around the esophagus and stomach.
But THE BEST NEWS is that success stories continue to come in. Success stories #34 to #38 were reported to me in the last 4 weeks. And the stories continue to report that the research linked above proves that the regimen appears to continue to be cancer agnostic.
He had joined a Facebook group site called Lung Cancer Survivors and Support Group, run by a guy named Mark Peitzmeier and a lady named Kelly Miller. Their group has 8,800 members (compared to 100,000 here)
10 months ago, Rick had 4th stage metastasized melanoma that had metastasized to his liver and lungs. His doctors wanted to put him on auto-immune boosters, but frankly told him he only had 6 or so months to live.
Success stories #41 through #45 are in, but I simply have been buried with work and travel.
I have a couple of hours of downtime, so I thought it might be helpful to recap some of the more interesting top 20 success stories other than myself:
As noted previously, the Oklahoma Medical Research Foundation is in the process of auditing and building a data base of key success cases. But it gets more exciting.